Landscapes / Companies
Pharmosa Biopharm Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 4 in all
Trials
2 active
4 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
L608not checked |
— |
Phase 2 | 31 Dec 2028Phase 2 trial completes | ||
| Next date | 31 Dec 2028 · Phase 2 trial completes | ||||
| Also tested for | Systemic Sclerosis | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2026Phase 1 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1 trial completes | ||||
| Open drug page | |||||
About
- No active trial
- L606 Inhalation, L608 Inhalation
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021